INFORMATION FOR PATIENTS
INFORMATION FOR HEALTH PROFESSIONALS
IMMEDIATE TRIAL INFORMATION
What is IMMEDIATE GIK?
News and Events
Glossary of Terms
Articles and Resources
Preliminary Studies: Animal and early human research on GIK
Development and testing of aids for diagnosing a heart attack
Acute Cardiac Ischemia-Time Insensitive Predictive Instrument (ACI-TIPI) Trial
Annals of Internal Medicine. December 1, 1998; 129:11, 845-855
Development and testing of an aid for emergency treatment for a heart attack
Thrombolytic Predictive Instrument (TPI) Trial
Annals of Internal Medicine July 16, 2002; Volume 137: 2,87-95
IMMEDIATE Pilot Trial
3 month feasibility study of the administration of GIK in the prehospital setting. Conducted at Emerson Hospital and Emerson Hospital EMS; 115 patients screened, 29 enrolled.
National Institutes of Health’s (NIH) National Heart, Lung, Blood Institute (NHLBI) approves funding of Nationwide IMMEDIATE Trial
Massachusetts Dept. of Public Health Office of Emergency Medical Services approves waiver for special projects.
IMMEDIATE Trial enrollment began across the US.
IMMEDIATE Trial site expansion.
Enrollment into the Biological Mechanism Cohort began in April
Enrollment into the Genetic Ancillary Study began in June
patient was enrolled in the IMMEDIATE Trial in August
IMMEDIATE Trial and Genetic Ancillary Study enrollment completed
Community Consultation & Public Notification
What is a Clinical Trial?
Heart Attack Facts
Frequently Asked Questions
Biological Mechanism Cohort
Genetic Ancillary Study
Study Design and Procedures
ECG Predictive Instruments